Clavant Steven P, Forbes Josephine M, Thallas Vicki, Osicka Tanya M, Jerums George, Comper Wayne D
Department of Biochemistry and Molecular Biology, Monash University, Clayton, Vic., Australia.
Nephron Physiol. 2003;93(2):p51-60. doi: 10.1159/000068528.
Angiotensin II (ANG II) is intimately involved in normal renal function, and is estimated to exist at a normal physiological range of 6-10 nM within the renal tubules. The potential role that intrarenal ANG II may play in renal disease was assessed by perfusing isolated rat kidneys with or without excess intratubular levels of ANG II, which may mimic changes in the intrarenal RAS under pathological conditions. The effects of increased systemic ANG II were also determined by infusing rats with ANG II by osmotic pump. In isolated perfused kidneys, ANG II significantly and specifically increased the fractional clearance of albumin to clinical levels, as determined by using radiolabelled albumin. This effect was reversible, as removing ANG II from the perfusate caused the albumin fractional clearance to decrease to pre-ANG II exposure levels. The increase in fractional clearance of albumin was not correlated with renal hemodynamic changes, nor glomerular permeability alterations as measured by the fractional clearance of 36 A Ficoll and immunoglobulin G. Immunochemical analysis using anti-alpha-tubulin antibody of perfused kidney sections revealed that ANG II caused a marked disruption of tubular epithelial cytoskeletal components, through disassembly and reorganization of alpha-tubulin. This disruption was reversible. In vivo, osmotic pump delivery of ANG II at less potent dosage caused a proteinuria (Biuret) and an albuminuria (radioimmunoassay) in rats, from as early as 2 days after pump implantation. These results demonstrate that ANG II may reversibly induce clinical levels of albuminuria. These data point to an important role for renal tubules and the intratubular lumen concentrations of ANG II in the renal processing of albumin.
血管紧张素II(ANG II)与正常肾功能密切相关,据估计在肾小管内其正常生理范围为6 - 10 nM。通过向离体大鼠肾脏灌注有无过量肾小管内水平的ANG II来评估肾内ANG II在肾脏疾病中可能发挥的潜在作用,这可能模拟病理条件下肾内肾素 - 血管紧张素系统(RAS)的变化。还通过渗透泵向大鼠输注ANG II来确定全身ANG II升高的影响。在离体灌注肾脏中,使用放射性标记白蛋白测定发现,ANG II显著且特异性地将白蛋白分数清除率提高到临床水平。这种作用是可逆的,因为从灌注液中去除ANG II会导致白蛋白分数清除率降至ANG II暴露前水平。白蛋白分数清除率的增加与肾血流动力学变化无关,也与通过36 A Ficoll和免疫球蛋白G分数清除率测量的肾小球通透性改变无关。使用抗α - 微管蛋白抗体对灌注肾脏切片进行免疫化学分析显示,ANG II通过α - 微管蛋白的解聚和重组导致肾小管上皮细胞骨架成分明显破坏。这种破坏是可逆的。在体内,以较低有效剂量通过渗透泵给予ANG II,早在泵植入后2天就使大鼠出现蛋白尿(双缩脲法)和白蛋白尿(放射免疫分析法)。这些结果表明ANG II可能可逆地诱导临床水平的白蛋白尿。这些数据表明肾小管以及肾内ANG II的肾小管内管腔浓度在肾脏处理白蛋白过程中起重要作用。